NeuroPace Files 8-K: Regulation FD & Exhibits
Ticker: NPCE · Form: 8-K · Filed: Apr 14, 2025 · CIK: 1528287
| Field | Detail |
|---|---|
| Company | Neuropace Inc (NPCE) |
| Form Type | 8-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K, financial-exhibits
TL;DR
NeuroPace filed an 8-K for Reg FD and exhibits. Nothing major disclosed yet.
AI Summary
On April 14, 2025, NeuroPace, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided excerpt.
Why It Matters
This filing indicates NeuroPace is complying with regulatory disclosure requirements and providing necessary financial exhibits, which is standard practice for public companies.
Risk Assessment
Risk Level: low — The filing is a routine regulatory disclosure and does not contain information that suggests an immediate change in the company's risk profile.
Key Players & Entities
- NeuroPace, Inc. (company) — Registrant
- April 14, 2025 (date) — Date of earliest event reported
- 455 N. Bernardo Avenue (location) — Principal executive offices address
- Mountain View, CA (location) — City and State of principal executive offices
- 94043 (location) — ZIP code of principal executive offices
- 6502372700 (phone_number) — Registrant's telephone number
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not detail the specific content of the Regulation FD disclosure, only that it is an item being reported.
What financial statements and exhibits are included in this filing?
The excerpt lists 'Financial Statements and Exhibits' as an item information category but does not specify which statements or exhibits are included.
Has NeuroPace, Inc. undergone any recent significant corporate changes reported on this 8-K?
The excerpt does not mention any significant corporate changes; it focuses on the filing of the 8-K itself and its categories.
What is the primary purpose of this 8-K filing for NeuroPace, Inc. on April 14, 2025?
The primary purpose is to report current information as required by the SEC, specifically related to Regulation FD Disclosure and Financial Statements and Exhibits.
Is there any indication of new financial performance or guidance in this filing?
No, the provided text of the 8-K filing does not contain any specific financial performance figures or guidance.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding NeuroPace Inc (NPCE).